Cost-effectiveness analysis of filgotinib as a first-line treatment for biologic-naive patients with Ulcerative Colitis in Greece

The aim of this study was to evaluate the cost-effectiveness of introducing filgotinib as a treatment option for patients with moderate to severe Ulcerative Colitis(UC) who are biologic-naïve in Greece compared to adalimumab, golimumab and vedolizumab.

Publication Details

Journal
London School of Economics and Political Science Research Online (London School of Economics and Political Science)
Published
2024-12-31
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-effectiveness analysis of filgotinib as a first-line treatment for biologic-naive patients with Ulcerative Colitis in Greece

London School of Economics and Political Science Research Online (London School of Economics and Political Science)
Inflammatory Bowel Disease
article

Cost-effectiveness analysis of filgotinib as a first-line treatment for biologic-naive patients with Ulcerative Colitis in Greece

article en

Abstract

The aim of this study was to evaluate the cost-effectiveness of introducing filgotinib as a treatment option for patients with moderate to severe Ulcerative Colitis(UC) who are biologic-naïve in Greece compared to adalimumab, golimumab and vedolizumab.

London School of Economics and Political Science Research Online (London School of Economics and Political Science)
Good health and well-being
Openalex Percentile: Top 38%
Inflammatory Bowel Disease
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cost-effectiveness analysis of filgotinib as a first-line treatment for biologic-naive patients with Ulcerative Colitis in Greece · London School of Economics and Political Science Research Online (London School of Economics and Political Science) (2024) | TGRS Research Map | TGRS